Botulinum toxin A injection in the prevention of facial trauma or postoperative hypertrophic scar: a systemic review of effectiveness and safety

doi:10.3969/j.issn.2095-4344.2778

Abstract

Abstract:

BACKGROUND: Facial scars are mainly caused by trauma or surgery, which greatly affect the appearance. Dermatologists and plastic surgeons have tried many ways to change the appearance of scars. Botulinum toxin A injection is widely used in clinical practice for prevention of scars, but the efficacy and safety are not proved.

OBJECTIVE: To evaluate the effectiveness and safety of botulinum toxin A injection in the prevention of facial trauma or postoperative hypertrophic scar.

METHODS: PubMed, EMbase, the Cochrane library, CNKI, CBM, WanFang, and VIP were searched for randomized controlled trials regarding botulinum toxin A injection in the prevention of facial scars. Manual retrieval was done for supplement of incomplete data. Two doctors were responsible for literature screen and evaluation. Finally, 11 randomized controlled clinical trials were included. The experimental group was injected with botulinum toxin A, and the control group was given saline or nothing. Part of the data was analyzed using Revman 5.3 software for meta-analysis, and the data that could not be analyzed using software were subjected to a descriptive analysis.

RESULTS AND CONCLUSION: Eleven randomized controlled trials were included, involving 436 patients with 518 wounds. Meta-analyses showed that Vancouver scar scale score, visual analogue scale score and width of scars in the botulinum toxin A group were significantly better than those in the control group (weighted mean difference (WMD)=-1.61, 95% confidence interval (CI)=-2.06 to -0.26, P = 0.02; WMD=1.7, 95%CI=0.38 to 3.02, P = 0.01; WMD=-0.17, 95%CI=-0.22 to -0.12, P < 0.000 1). Incidence of adverse reactions of botulinum toxin A group was higher than that in the control group (χ²=8.335, P=0.004), but they were all slight and easy to release. There were no serious adverse events in both groups. It seems that botulinum toxin A injection can reduce the width of scars, improve Vancouver scale and visual analogue scale scores. However, it is suggested to make clear communication before and after the operation and take measures to deal with various adverse reactions in advance.

Key words: botulinum toxin A, hypertrophic scar, Vancouver scar scale, visual analogue scale, patient scar assessment scale, observer scar assessment scale, systematic evaluation, meta-analysis

CLC Number:

Song Li, Ye Junru, Lu Mao, Tang Yi, Liu Yanlin, Chen Ximao. Botulinum toxin A injection in the prevention of facial trauma or postoperative hypertrophic scar: a systemic review of effectiveness and safety[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(29): 4744-4750.

Figures/Tables 9

References

[1] BIJLARD E, KOUWENBERG CA,TIMMAN R, et al. Burden of keloid disease: a cross-sectional health-related qualit y of life assessment. Acta Derm Venereol.2017;97(2):225-229.

[2] OOSTERWIJK AM, MOUTON LJ, SCHOUTEN H, et al. Prevalence of scar contractures after burn: a systematic review.Burns.2017;43(1): 41-49.

[3] MARTINS JMP, OLIVEIRA FDS, LIMA EOC, et al. Use of derived adipose stem cells to reduce complications of c utaneous scarring in smokers. An experimental model in rats.Acta Cir Bras.2019;34(6): e201900605.

[4] MENEZES MCS, VASCONCELLOS LS, NUNES CB, et al. Evaluation of the use of tacrolimus ointment for the preve ntion of hypertrophic scars in experimental model.An Bras Dermatol.2019;94(2):164-171.

[5] 于水,王雅文,赵梓纲.A 型肉毒素在皮肤科的应用现状和前景[J].中国皮肤性病学杂志,2018,32(1):101-104.

[6] KASYANJU CARRERO LM, MA WW, LIU HF, et al. Botulinum toxin type A for the treatment and prevention of h ypertrophic scars and keloids: Updated review.J Cosmet Dermatol.2019;18(1):10-15.

[7] PRODROMIDOU A, FROUNTZAS M, VLACHOS DE, et al. Botulinum toxin for the prevention and healing of woun d scars: A systematic review of the literature.Plast Surg.2015;23(4): 260-264.

[8] HU L, ZOU Y, CHANG SJ, et al. Effects of botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial.Plast Reconstr Surg.2018;141(3):646-650.

[9] LEE SH, MIN HJ, KIM YW, et al. The efficacy and safety of early postoperative botulinum toxin A injectio n for facial scars.Aesthet Plast Surg.2018;42(2):530-537.

[10] ZELKEN J, YANG SY, CHANG CS, et al. Donor site aesthetic enhancement with preoperative botulinum toxin in f orehead flap nasal reconstruction.Ann Plast Surg.2016;77(5):535-538.

[11] CHANG CS, WALLACE CG, HSIAO YC, et al.Botulinum toxin to improve results in cleft lip repair. Plast Reco nstr Surg.2014;134(3):511-516.

[12] CHANG CS, WALLACE CG, HSIAO YC, et al. Botulinum toxin to improve results in cleft lip repair: a doubleblind ed, randomized, vehicle-controlled clinical trial.PLoS ONE.2014;9(12):e115690.

[13] ZIADE M, DOMERGUE S, BATIFOL D, et al. Use of botulinum toxin type A to improve treatment of facial woun ds: a prospective randomised study.J Plast Reconstr Aesthet Surg.2013;66(2):209-214.

[14] GASSNER HG, BRISSETT AE, OTLEY CC, et al. Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study.Mayo Clin Proc.2006;81(8):1023-1028.

[15] 李卫华,高玉伟,孙志成.A型肉毒毒素在面部直线形瘢痕修复术中的应用[J].中国美容整形外科杂志,2014,25(7):426-429.

[16] 陶谏,刘宾,汪阳,等.A 型肉毒毒素对减轻额部术后瘢痕增生的临床研究[J].陕西医学杂志,2018,47(8):1011-1013.

[17] 徐志刚,胡大海.A 型肉毒毒素减轻面部整形切口瘢痕的临床观察[J].安徽医药,2019,23(5):1010-1013.

[18] KIM SH, LEE SJ, LEE JW, et al. Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study. Medicine (Baltimore).2019;98(34):e16952.

[19] LI YH, YANG J, LIU JQ, et al. A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of B otulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound.A esthetic Plast Surg.2018;42(5):1364-1369.

[20] KIM YS, LEE HJ, CHO SH, et al. Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial.Wound Repair Regen.2014;22(5):605-612.

[21] 王小玉,王小琴,刘琰,等.面部小面积瘢痕手术切口早期应用A型肉毒毒素注射联合强脉冲光照射的临床效果[J].实用皮肤病学杂志,2013,6(5): 271-273.

[22] 杨萍,张子玉.A型肉毒毒素联合减张压迫法于面部整形切口愈合应用中的临床分析[J].中外女性健康研究,2017,18:59-64.

[23] 汪阳,张颖,田婧.局部注射 A 型肉毒毒素对额颞部良性肿瘤切除术后切口瘢痕增生的防治作用[J].河北医学, 2017,23(3):486-489.

[24] 杨瑞年,李明,吴承道.面部整形美容切口中A型肉毒毒素联合减张压迫法应用研究[J].中国医疗美容,2014,(6);3.

[25] 卫东.Botox A 早期切口内注射联合减张法对面部小面积瘢痕手术切口恢复效果的影响[J].医学研究杂志,2017,46(6):133-136.

[26] 刘涛,杨德发.A 型肉毒毒素+减张压迫法用于面部整形美容切口中的研究[J].中国医疗美容,2017,7(5):7-9.

[27] WILSON AM. Use of botulinum toxin type A to prevent widening of facial scars.Plast Reconstr Surg.2006;117(6):1758-1766.

[28] XIAO Z, ZHANG F, CUI Z. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg.2009;33(3):409-412.

[29] GASSNER HG, SHERRIS DA, OTLEY CC. Treatment of facial wounds with botulinum toxin A improves cosmetic o utcome in primates.Plast Reconstr Surg.2000;105(6):1948-1953; discussion 1954-5.

[30] SHERRIS DA, GASSNER HG. Botulinum toxin to minimize facial scarring.Facial Plast Surg.2002;18(1):35-39.

[31] PRODROMIDOU A, FROUNTZAS M, VLACHOS DE, et al. Botulinum toxin for the prevention and healing of wound sca rs: A systematic review of the literature.Plast Surg.2015;23(4):260-264.

[32] ZHANG DZ, LIU XY, XIAO WL, et al. Botulinum Toxin Type A and the Prevention of Hypertrophic Scars on t he Maxillofacial Area and Neck: A Meta-Analysis of Randomized Controlled Trials. PLoS One.2016; 11(3): e0151627.

[33] WANG Y, WANG J, ZHANG J, et al. Effectiveness and Safety of Botulinum Toxin Type A Injection for Scar Preve ntion: A Systematic Review and Meta-analysis.AestheticPlast Surg.2019;43(5):1241-1249.

[34] 常宁,李广帅,刘林嶓,等.术后行肉毒毒素注射对切口愈合效果影响的Meta分析[J].中国美容医学,2015;24 (23):17-20.

[35] GILLANDERS SL, ANDERSON S, MELLON L, et al. A systematic review and Meta-analysis: Do absorbable or non-abso rbable suture materials differ in cosmetic outcomes in patients requiring primary closure of facial wounds? J Plast Reconstr Aesthet Surg.2018;71(12): 1682-1692.

[36] COHEN JL, SCUDERI N. Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.Aesthet Surg J.2017;37(suppl_1):S32-S44.